发明名称 |
Substituted imidazo[1,5-A]quinoxalin-4-ones are useful for preventing or treating storage dysfunction, voiding dysfunction and bladder/urethral diseases |
摘要 |
Substituted imidazo[1,5-a]quinoxalin-4-one compounds of formula (I) described herein exhibit PDE9-inhibitory action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like. |
申请公布号 |
US8901126(B2) |
申请公布日期 |
2014.12.02 |
申请号 |
US201313788770 |
申请日期 |
2013.03.07 |
申请人 |
Astellas Pharma Inc. |
发明人 |
Kaizawa Hiroyuki;Sugita Mari;Yamamoto Hirofumi;Kamijo Kazunori;Tsuchiya Kazuyuki;Seo Ryushi;Yamamoto Satoshi |
分类号 |
A61K31/4985;C07D241/38;C07D487/04;C07D519/00 |
主分类号 |
A61K31/4985 |
代理机构 |
Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P. |
代理人 |
Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P. |
主权项 |
1. A compound selected from the group consisting of
(+)-7-[(5-methoxy-2,3-dihydro-1H-pyrrolo[2,3-c]pyridin-1-yl)carbonyl]-8-methyl-1-(tetrahydrofuran-3-yl)imidazo[1,5-a]quinoxalin-4(5H)-one, (+)-7-[(5-methoxy-2,3-dihydro-1H-pyrrolo[2,3-c]pyridin-1-yl)carbonyl]-8-(methoxymethyl)-1-(tetrahydrofuran-3-yl)imidazo[1,5-a]quinoxalin-4(5H)-one, (+)-8-(methoxymethyl)-7-[(5-methyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-1-yl)carbonyl]-1-(tetrahydrofuran-3-yl)imidazo[1,5-a]quinoxalin-4(5H)-one, (+)-7-[(5-bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-1-yl)carbonyl]-8-methyl-1-(tetrahydrofuran-3-yl)imidazo[1,5-a]quinoxalin-4(5H)-one, (+)-7-[(5-bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-1-yl)carbonyl]-8-(methoxymethyl)-1-(tetrahydrofuran-3-yl)imidazo[1,5-a]quinoxalin-4(5H)-one; and (+)-7-[(5,6-difluoro-2,3-dihydro-1H-indol-1-yl)carbonyl]-8-methyl-1-(tetrahydrofuran-3-yl)imidazo[1,5-a]quinoxalin-4(5H)-one; or a pharmaceutically acceptable salt of said compound. |
地址 |
Tokyo JP |